{"id":53699,"date":"2023-02-07T18:02:13","date_gmt":"2023-02-07T17:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/"},"modified":"2023-02-07T18:02:13","modified_gmt":"2023-02-07T17:02:13","slug":"newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/","title":{"rendered":"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease"},"content":{"rendered":"
\n

\nA significant recognition of the groundbreaking approach of the Digital Medicines and Digital Therapeutic company<\/i>\n<\/p>\n

SALERNO, Italy–(BUSINESS WIRE)–Newel Health<\/a><\/b><\/span> announced today that it was selected to receive a grant from The Michael J. Fox Foundation for Parkinson\u2019s Research (MJFF) <\/i><\/b>[MJFF-022711] to advance the research and development of Soturi<\/a><\/b><\/span>, a Digital Therapeutic (DTx) solution for personalized medication and treatment plan optimization for people with Parkinson\u2019s disease.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nBorn from an investment play by Healthware Ventures and led by industry experts Gerry Chill\u00e8 and PierPaolo Iagulli, Newel Health is an innovative company that aims to improve healthcare for patients and doctors through the creation of beautifully designed and clinically validated digital medicine and digital therapeutic (DTx) solutions. Built on a strong heritage in health innovation, Newel Health works in partnership with pharmaceutical companies, medical device manufacturers and other health and wellness stakeholders.\n<\/p>\n

\nGerry Chill\u00e8, Chief Strategy and Innovation Officer, Newel Health, <\/i>said: \u201cThe Soturi app, developed in partnership with Orion Corporation, seeks to improve the lives of people living with Parkinson\u2019s disease (PD) using data collected from a wearable sensor to determine how people are being impacted by PD in a free-living context. Soturi\u2019s proprietary algorithms analyze the collected data to determine optimal treatment plan specific to the individual. It is an honor to have The Michael J. Fox Foundation fund our team\u2019s innovative approach and the potential benefits that our digital solution can deliver to the PD community.\u201d\n<\/p>\n

\nPierPaolo Iagulli, Chief Operating Officer, Newel Health<\/i>, explained: \u201cAt Newel Health, we aim to create solutions like Soturi that can truly make a difference in people’s lives, by harnessing the power of data and technology and keeping the human touch at the forefront of our products. As we continue with this mission, H.Core, our proprietary software framework, propels us in accelerating the design, validation, production, and launch of all digital therapeutics and digital medicines.\u201d\n<\/p>\n

\nRoberto Ascione, Chairman of the Board of Healthware Ventures<\/i>, said: “Congratulations to the team for all their dedication to this new venture and the hard work spent on these innovative solutions. This grant from The Michael J. Fox Foundation marks the first of many important milestones for the company as it continues to develop its portfolio of digital solutions so that the health journeys of people living with health conditions and their doctors\u2019 efforts, will become as clear and successful as can be.\u201d\n<\/p>\n

\nAbout Newel Health<\/b>\n<\/p>\n

\nNewel Health is an innovative company that aims to improve the lives of people that live with a health condition and their doctors through the creation of beautifully designed and clinically validated digital medicine (DM) and digital therapeutic (DTx) solutions.\n<\/p>\n

\nBorn from an investment play by Healthware Ventures, the company has executed a series of strategic acquisitions of early- stage startups which now constitute a portion of its products\u2019 pipeline.\n<\/p>\n

\nIts team of experts, comprised of professionals in digital, data, behavioral, and scientific fields, have extensive experience in the life sciences industry.\n<\/p>\n

\nStrategically partnering with pharmaceutical, medical device, and other health and wellness companies allows Newel Health to expand its customer reach and achieve its vision of future health. A long history of industry partnerships and a focus on patient-centricity enables successful outcomes in these shared initiatives.\n<\/p>\n

\nNewel Health sprints out of the gate with two digital solutions: Amicomed, a Hypertension Control program that helps people lower their blood pressure via analytic insights of longitudinal blood pressure measurements and highly personalized behavioral lifestyle modification programs, and Soturi, a suite of digital services and smart algorithms that personalize and optimize the medication and treatment plans for people living with Parkinson\u2019s disease.\n<\/p>\n

\nThe company actively researches and develops new digital product concepts in additional therapeutic areas with the goal of entering new partnerships and extending its portfolio of DTx solutions.\n<\/p>\n

\nNewel Health also owns H.Core, a proprietary rapid-development SaMD (medical device software) framework designed to accelerate the design, validation, production, and launch of DM and DTx solutions.\n<\/p>\n

\nFor more information, please visit newel.health<\/a> and follow us on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nContact Information<\/b>\n<\/p>\n

\nM<\/i><\/b>edia<\/b><\/i>
Antonietta Pannella
\n
Email: antonietta.pannella@healthwaregroup.com<\/a>
Mobile: +39 349.0648276\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

A significant recognition of the groundbreaking approach of the Digital Medicines and Digital Therapeutic company SALERNO, Italy–(BUSINESS WIRE)–Newel Health announced today that it was selected to receive a grant from The Michael J. Fox Foundation for Parkinson\u2019s Research (MJFF) [MJFF-022711] to advance the research and development of Soturi, a Digital Therapeutic (DTx) solution for personalized … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53699","6":"format-standard","7":"category-industry"},"yoast_head":"\nNewel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"A significant recognition of the groundbreaking approach of the Digital Medicines and Digital Therapeutic company SALERNO, Italy–(BUSINESS WIRE)–Newel Health announced today that it was selected to receive a grant from The Michael J. Fox Foundation for Parkinson\u2019s Research (MJFF) [MJFF-022711] to advance the research and development of Soturi, a Digital Therapeutic (DTx) solution for personalized ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-07T17:02:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230207005801\/en\/1707147\/21\/Newel_health%2BSoturi%402x.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease\",\"datePublished\":\"2023-02-07T17:02:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/\"},\"wordCount\":717,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230207005801\\\/en\\\/1707147\\\/21\\\/Newel_health%2BSoturi%402x.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/\",\"name\":\"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230207005801\\\/en\\\/1707147\\\/21\\\/Newel_health%2BSoturi%402x.jpg\",\"datePublished\":\"2023-02-07T17:02:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230207005801\\\/en\\\/1707147\\\/21\\\/Newel_health%2BSoturi%402x.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230207005801\\\/en\\\/1707147\\\/21\\\/Newel_health%2BSoturi%402x.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/","og_locale":"en_US","og_type":"article","og_title":"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease - Pharma Trend","og_description":"A significant recognition of the groundbreaking approach of the Digital Medicines and Digital Therapeutic company SALERNO, Italy–(BUSINESS WIRE)–Newel Health announced today that it was selected to receive a grant from The Michael J. Fox Foundation for Parkinson\u2019s Research (MJFF) [MJFF-022711] to advance the research and development of Soturi, a Digital Therapeutic (DTx) solution for personalized ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-07T17:02:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230207005801\/en\/1707147\/21\/Newel_health%2BSoturi%402x.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease","datePublished":"2023-02-07T17:02:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/"},"wordCount":717,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230207005801\/en\/1707147\/21\/Newel_health%2BSoturi%402x.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/","url":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/","name":"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230207005801\/en\/1707147\/21\/Newel_health%2BSoturi%402x.jpg","datePublished":"2023-02-07T17:02:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230207005801\/en\/1707147\/21\/Newel_health%2BSoturi%402x.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230207005801\/en\/1707147\/21\/Newel_health%2BSoturi%402x.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/newel-health-awarded-2-5m-research-grant-from-the-michael-j-fox-foundation-for-further-development-of-soturi-an-innovative-digital-therapeutic-solution-for-people-living-with-parkinsons-di\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Newel Health Awarded $2.5M Research Grant from The Michael J. Fox Foundation for Further Development of Soturi, an Innovative Digital Therapeutic Solution for People Living with Parkinson\u2019s Disease"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53699"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53699\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}